MMJ International Holdings

MMJ International Holdings has joined federal litigation challenging the United States===Centers for Medicare & Medicaid Services' BEI program. The company is developing FDA-authorized cannabinoid therapies and argues that the BEI program undermines the regulatory pathway for pharmaceutical cannabinoid medicines, potentially weakening investor confidence and clinical trial recruitment.